NCT05241340 Neoadjuvant Sasanlimab With Radiation as an in Situ Vaccine for Cisplatin-ineligible Muscle Invasive Bladder Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05238311 Pre-approval Single-patient Expanded Access for Elranatamab (PF-06863135) Status NO_LONGER_AVAILABLE Phase N/A
NCT05233436 PF-07265028 As Single Agent And In Combination With Sasanlimab in Advanced or Metastatic Solid Tumors Status TERMINATED Phase PHASE1
NCT05228470 A Study of Elranatamab (PF-06863135) in Chinese Participants With Refractory Multiple Myeloma. Status COMPLETED Phase PHASE2
NCT05227001 A Study To Learn About The Study Vaccine (Called Self-Amplifying Ribonucleic Acid (RNA)) For The Prevention of Influenza Status COMPLETED Phase PHASE1
NCT05226871 Study for Participants Continuing From Pfizer-sponsored Palbociclib (a Study Medicine) Studies Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05224609 A Study to Learn About the Study Medicine (Called Lorlatinib) in People With Liver Dysfunction Status COMPLETED Phase PHASE1
NCT05217927 Efficacy and Safety Study of Rimegepant in Episodic Migraine Prevention With Multiple Dosing Regimens Status COMPLETED Phase PHASE4
NCT05217446 A Study of Encorafenib Plus Cetuximab Taken Together With Pembrolizumab Compared to Pembrolizumab Alone in People With Previously Untreated Metastatic Colorectal Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05207865 Safety and Tolerability Study of Daily Dosing Rimegepant in Episodic Migraine Prevention Status COMPLETED Phase PHASE4
NCT05206604 A First-in-human Study of Multiple Doses of Topically Administered PF-07295324 and PF-07259955 Status COMPLETED Phase PHASE1
NCT05203172 The FLOTILLA Study: Providing Continued Access to The Study Medicines Encorafenib and Binimetinib for Participants in Prior Clinical Trials Status RECRUITING Phase PHASE4
NCT05200403 Improvement In Scratch Behavior And Sleep In Patients With Atopic Dermatitis Status TERMINATED Phase PHASE4
NCT05199766 Hemolysis Related Complications in SCD. A Phase II Study With Voxelotor Status UNKNOWN Phase PHASE2
NCT05199051 A Phase 2 Study of Gemtuzumab Ozogamicin (GO)-Gilteritinib Combination in Adults With FLT3-ITD and/or FLT3-TKD Relapse/Refractory (R/R) AML Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05198245 Study of Pregnancy Outcomes in Women Exposed to Rimegepant During Pregnancy Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05195814 A Study to Learn About the Study Medicine (Called Tofacitinib) in People With Psoriatic Arthritis Status COMPLETED Phase N/A
NCT05194579 Pharmacokinetic Comparability Study in Healthy Participants - PF-06881894 On-Body Injector Relative to Prefilled Syringe Status COMPLETED Phase PHASE1